Enanta Pharmaceuticals
Enanta Pharmaceuticals is a biotechnology company focused on the research and development of small molecule drugs for viral infections and liver diseases. Leveraging its expertise in chemistry and drug discovery, Enanta develops innovative therapies targeting conditions such as hepatitis B, respiratory syncytial virus (RSV), and SARS-CoV-2. The company’s robust pipeline features proprietary compounds designed to address significant unmet medical needs. Enanta Pharmaceuticals partners with leading pharmaceutical organizations to advance its clinical programs and expand its impact in the field of antiviral therapeutics. Committed to scientific excellence, Enanta continues to drive progress in the development of novel treatments that improve patient outcomes worldwide.
